C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 487/04 (2006.01) A61K 31/519 (2006.01) A61P 3/04 (2006.01) A61P 3/10 (2006.01)
Patent
CA 2732165
A compound of Formula (I) is useful in the treatment or prevention of a disease or medical condition mediated through glucokinase (GLK or GK), leading to a decreased glucose threshold for insulin secretion.
L'invention porte sur un composé représenté par la formule (I) utile pour le traitement ou la prévention d'une maladie ou d'un état médical à médiation par la glucokinase (GLK ou GK) qui baisse le seuil de sécrétion d'insuline.
Bennett Stuart Norman Lile
Bonn Peter Gustaf
Brink Mikael Dan
Butlin Roger John
Campbell Leonie
Astrazeneca Ab
Fetherstonhaugh & Co.
LandOfFree
Therapeutic agents 414 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic agents 414, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic agents 414 will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1521382